| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/20/2005 | US20050014832 Treatment |
| 01/20/2005 | US20050014827 Formulations containing polyphenol derivatives; food and feed supplements; bactericidal, fungicidal and virucidal effects |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014806 Substituted isoxazoles and their use as antibiotics |
| 01/20/2005 | US20050014803 Enzyme inhibitors |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines |
| 01/20/2005 | US20050014731 Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds |
| 01/20/2005 | US20050014730 Anti-fungal formulation of triterpene and essential oil |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | US20050014718 Tumor specific oligosaccharide sequences and use thereof |
| 01/20/2005 | US20050014717 Composition and method for viral inhibition |
| 01/20/2005 | US20050014707 6,11-4C-bicyclic 9a-azalide derivatives |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014703 Cell differentiation, regeneration of epithelium pancreas cells into insulin producing beta-cells; administrering a peptidyl- peptidase activator |
| 01/20/2005 | US20050014702 Inhibition of pdf enzyme as bactericidal agents for veterinary medicines |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014688 Inducer of apoptosis |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014230 Generating immunoglobulin specific for human lymphadenopathy viral glycoprotein 120 for use in prevention and treatment of viral diseases; immunotherapy |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014149 Assay for inhibitors of translocases |
| 01/20/2005 | US20050013876 Inactivation of papillomavirus |
| 01/20/2005 | US20050013858 Sustained release formulation; shorter treatment duration; higher tolerance; fungal infections |
| 01/20/2005 | US20050013831 Obtained from neisseria meningitidis and commensal neisseria; broad spectrum protective immunity |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013823 Administering to animal at 3 to 10 days of age; swine |
| 01/20/2005 | US20050013822 Invaplex from gram negative bacteria, method of purification and methods of use |
| 01/20/2005 | US20050013801 Concurrently administering Interferon alpha and gamma; reducing incidence of complications |
| 01/20/2005 | DE10320780A1 Heterocyclyl-substituierte Dihydrochinazoline Heterocyclyl-substituted dihydroquinazolines |
| 01/20/2005 | CA2531790A1 Compound having anti-hcv action and its production method |
| 01/20/2005 | CA2531757A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 01/20/2005 | CA2531636A1 Compositions for activating the infiltration activity of dendritic cells and immunopotentiating agents |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/20/2005 | CA2531512A1 Organosilicon compounds and their use |
| 01/20/2005 | CA2531511A1 Silicon compounds and their use |
| 01/20/2005 | CA2531283A1 Specific human antibodies |
| 01/20/2005 | CA2530838A1 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 01/20/2005 | CA2529294A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | CA2529293A1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | CA2529292A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | CA2528336A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 01/19/2005 | EP1498491A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO Fc GAMMA RECEPTOR IIIa |
| 01/19/2005 | EP1498490A1 Process for producing antibody composition |
| 01/19/2005 | EP1498485A1 Cells with modified genome |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498426A1 Preparation of fully human antibodies |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1498139A1 Novel thrombomodulin expression promoters |
| 01/19/2005 | EP1498138A1 Preventives for hiv infection |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498119A1 Use of conjugated linoleic acid for treating colds |
| 01/19/2005 | EP1497662A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis |
| 01/19/2005 | EP1497470A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 01/19/2005 | EP1497438A1 Means and methods for the production of adenovirus vectors |
| 01/19/2005 | EP1497412A2 Adenovirus vectors for immunotherapy |
| 01/19/2005 | EP1497401A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 01/19/2005 | EP1497324A2 CD4 sp + /sp T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES |
| 01/19/2005 | EP1497322A2 Treatment of infections and other disorders |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497298A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents |
| 01/19/2005 | EP1497286A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1496945A1 Mycoplasma polypeptides |
| 01/19/2005 | EP1496941A1 Glycodendrimers having biological activity |
| 01/19/2005 | EP1496934A2 Adjuvant enhanced immunotherapy |
| 01/19/2005 | EP1496932A2 Anti-hiv composition, production method thereof and medicament |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496919A2 Immobilisation and stabilisation of virus |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496899A1 Use of materials having zinc ionophoric behavior |
| 01/19/2005 | EP1496893A2 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496887A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 01/19/2005 | EP1496885A1 Use of conjugated linoleic acid derivatives |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1496863A2 Preparation and use of a stable formulation of allosteric effector compounds |
| 01/19/2005 | EP1496836A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 01/19/2005 | EP1496742A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1313738A4 Process for the preparation and purification of thiol-containing maytansinoids |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | EP1124562B1 Combination therapy to treat hepatitis b virus |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | EP0831813B1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 01/19/2005 | EP0804074B1 Treating red blood cell solutions with anti-viral agents |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568369A Hybrid interferon/interferon Tau proteins, compositions and methods of use |
| 01/19/2005 | CN1568365A Composition comprising a lactobacillus pentosus strain and uses thereof |